Avelumab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Avelumab
Jul 23, 2024, 00:19 |
Blog
Jun Gong: Podcast on mUC and how maintenance avelumab fits into the global 1L paradigm
Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared a…
Jun 21, 2024, 04:41 |
Insight
Davide Ciardiello: Cetuximab and Avelumab in patients with colorectal cancer liver metastasis
Davide Ciardiello, Oncologist at the Medical Oncology Division of Gastrointestinal and Neuroendocrine Tumors at European…
Jun 11, 2024, 06:28 |
Blog
Tanja Obradovic: Intriguing results reported at ASCO24
Tanja Obradovic shared a post on LinkedIn: ''What about intriguing results reported at ASCO24? One…
Jun 8, 2024, 16:06 |
Blog
Reflections on ASCO24 by Jill Feldman
Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…
Jun 6, 2024, 13:18 |
Blog
María Natalia Gandur Quiroga on JAVELIN Renal 101 trial by Camillo Porta
María Natalia Gandur Quiroga shared on X/Twitter: ''In It for the Long Run: Updated Outcomes…
Jun 3, 2024, 15:09 |
Insight
Avelumab + Axitinib Did Not Improve Overall Survival in Patients with Metastatic Renal Cell Carcinoma: Don't Panic!
"Final overall survival (OS) and progression-free survival (PFS) results for patients with metastatic clear cell…
May 28, 2024, 14:33 |
Societies
Tom Powles: Final results for axitinib/avelumab in 1st line RCC at ASCO24
Tom Powles, Director of Barts Cancer Center, shared on X: "Final results for axitinib/avelumab in 1st…
Apr 16, 2024, 11:36 |
Insight
Piotr Wysocki: Rechallenge with anti-EGFR antibodies is a feasible and safe strategy in refractory metastatic colorectal cancer patients with RAS/BRAFwt ctDNA
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 11, 2024, 08:13 |
Drugs
Tom Powles: Disitimab, Vedotin and Pembrolizumab vs chemotherapy with or without Avelumab in advanced Urothelial Carcinoma
Tom Powles, Director of Barts Cancer Center, recently shared on X: “Trial in progress: The…
Apr 10, 2024, 05:06 |
Insight
Toni Choueiri: The Renee Saliby kidney cancer biomarker paper in Cancer Cell is online with a detailed tweetorial
Toni Choueiri shared a post by Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber…
Mar 27, 2024, 10:07 |
Insight
Piotr Wysocki: No benefit of continuing CDK4/6i beyond progression in advanced ER+/HER2- breast cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Feb 16, 2024, 17:48 |
Blog
Mohammad Jad Moussa: "La Crème de La Crème" panel discussing wealthy outcomes from the UNITE study
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, recently shared…
Feb 1, 2024, 17:24 |
Drugs
Day 2 of GU24 ASCO Highlights by Oncology Brothers
Oncology Brothers shared on their X/Twitter: "Day 2 of GU24 ASCO Highlights 1. UNITE: EV…
Oct 23, 2023, 15:26 |
Insight
Tom Powles: Enfortumab vedotin and Pembrolizumab improving PFS and OS by 55% and 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%)
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: "Enfortumab vedotin and Pembrolizumab improving…
Sep 5, 2023, 17:48 |
Blog
Rasha Aboelhassan: Being the last speaker is a challenge, but usually, your exciting subject and professional presentation can make your job easier.
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital for Research and Treatment, recently shared…
All:
15
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube